Cargando…

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

BACKGROUND: Pulmonary hypertension (PH) associated to idiopathic pulmonary fibrosis (IPF) portends a poor prognosis. IL-11 has been implicated in fibrotic diseases, but their role on pulmonary vessels is unknown. Here we analyzed the contribution of IL-11 to PH in patients with IPF and the potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milara, Javier, Roger, Inés, Montero, Paula, Artigues, Enrique, Escrivá, Juan, Cortijo, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664718/ https://www.ncbi.nlm.nih.gov/pubmed/36376885 http://dx.doi.org/10.1186/s12931-022-02241-0

Ejemplares similares

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
por: Roger, Inés, et al.
Publicado: (2021)

Senescence Alterations in Pulmonary Hypertension
por: Roger, Inés, et al.
Publicado: (2021)

The JAK2 pathway is activated in idiopathic pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2018)

MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway
por: Ballester, Beatriz, et al.
Publicado: (2021)

Mucins as a New Frontier in Pulmonary Fibrosis
por: Ballester, Beatriz, et al.
Publicado: (2019)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
por: Ballester, Beatriz, et al.
Publicado: (2019)

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
por: Montero, Paula, et al.
Publicado: (2021)

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
por: Estornut, Cristina, et al.
Publicado: (2022)

Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells
por: Montero, Paula, et al.
Publicado: (2023)

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
por: Milara, Javier, et al.
Publicado: (2018)

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview
por: Roger, Inés, et al.
Publicado: (2023)

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
por: Peiró, Teresa, et al.
Publicado: (2022)

Obacunone Photoprotective Effects against Solar-Simulated Radiation–Induced Molecular Modifications in Primary Keratinocytes and Full-Thickness Human Skin
por: Montero, Paula, et al.
Publicado: (2023)

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro
por: Roger, Inés, et al.
Publicado: (2022)

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model
por: Montero, Paula, et al.
Publicado: (2022)

Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model
por: Milara, Javier, et al.
Publicado: (2015)

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
por: Montero, Paula, et al.
Publicado: (2022)

Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
por: Calabrese, Fiorella, et al.
Publicado: (2013)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
por: Ballester, Beatriz, et al.
Publicado: (2020)

The role of mucin 1 in respiratory diseases
por: Ballester, Beatriz, et al.
Publicado: (2021)

N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
por: Milara, Javier, et al.
Publicado: (2022)

Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
por: Milara, Javier, et al.
Publicado: (2016)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Nitric Oxide System and Bronchial Epithelium: More Than a Barrier
por: Bayarri, María Amparo, et al.
Publicado: (2021)

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
por: Shi, Haixia, et al.
Publicado: (2023)

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
por: Chamorro, Virginia, et al.
Publicado: (2018)

Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps
por: Brunet, Aina, et al.
Publicado: (2023)

Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
por: Collum, Scott D., et al.
Publicado: (2017)

Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
por: Onda, Naomi, et al.
Publicado: (2014)

Effects of paclitaxel intervention on pulmonary vascular remodeling in rats with pulmonary hypertension
por: Zhao, Jian, et al.
Publicado: (2019)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

PGC-1α Induction in Pulmonary Arterial Hypertension
por: Mata, Manuel, et al.
Publicado: (2012)

Myocardial fibrosis with T1 mapping and right ventricular performance in pulmonary hypertension
por: Garcia-Lunar, Ines, et al.
Publicado: (2013)

Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension
por: Sato, Takahiro, et al.
Publicado: (2013)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
por: Collum, Scott D., et al.
Publicado: (2019)

Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease
por: Pastor-Clerigues, Alfonso, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_05isuhrmf7i7dtgpt6s054kpbi